NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Mologen AG (XETRA: MGNK)
MGNK Technical Analysis
5
As on 16th Dec 2021 MGNK STOCK Price closed @ 0.01 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.04 & Strong Sell for SHORT-TERM with Stoploss of 0.06 we also expect STOCK to react on Following IMPORTANT LEVELS. |
MGNKSTOCK Price
Open | 0.02 | Change | Price | % |
High | 0.02 | 1 Day | -0.01 | -50.00 |
Low | 0.01 | 1 Week | 0.00 | 0.00 |
Close | 0.01 | 1 Month | -0.01 | -50.00 |
Volume | 1932 | 1 Year | -0.08 | -88.89 |
52 Week High 0.09 | 52 Week Low 0.01 |
XETRA Germany Most Active Stocks
LHAR | 2.05 | -20.23% |
BBVA | 5.00 | -2.72% |
BBVA | 5.00 | -2.72% |
BBVA | 5.00 | -2.72% |
BVBA | 0.02 | -60.00% |
SNH | 0.16 | 6.67% |
SNH | 0.16 | 6.67% |
SNH | 0.16 | 6.67% |
PHIA | 31.36 | 1.92% |
PHIA | 31.36 | 1.92% |
XETRA Germany Top Gainers Stocks
XETRA Germany Top Losers Stocks
MGNK Daily Charts |
MGNK Intraday Charts |
Whats New @ Bazaartrend |
MGNK Free Analysis |
|
MGNK Important Levels Intraday
RESISTANCE | 0.03 |
RESISTANCE | 0.02 |
RESISTANCE | 0.02 |
RESISTANCE | 0.02 |
SUPPORT | 0.00 |
SUPPORT | 0.00 |
SUPPORT | 0.00 |
SUPPORT | -0.01 |
MGNK Forecast October 2024
4th UP Forecast | 0.09 |
3rd UP Forecast | 0.06 |
2nd UP Forecast | 0.05 |
1st UP Forecast | 0.03 |
1st DOWN Forecast | -0.01 |
2nd DOWN Forecast | -0.03 |
3rd DOWN Forecast | -0.04 |
4th DOWN Forecast | -0.07 |
MGNK Weekly Forecast
4th UP Forecast | 0.03 |
3rd UP Forecast | 0.02 |
2nd UP Forecast | 0.02 |
1st UP Forecast | 0.02 |
1st DOWN Forecast | 0.00 |
2nd DOWN Forecast | 0.00 |
3rd DOWN Forecast | 0.00 |
4th DOWN Forecast | -0.01 |
MGNK Forecast2024
4th UP Forecast | 0.18 |
3rd UP Forecast | 0.13 |
2nd UP Forecast | 0.09 |
1st UP Forecast | 0.06 |
1st DOWN Forecast | -0.04 |
2nd DOWN Forecast | -0.07 |
3rd DOWN Forecast | -0.11 |
4th DOWN Forecast | -0.16 |
Mologen AG ( XETRA Germany Symbol : MGNK )
Sector : N/A And Other Stocks in Same Sector
Sector : N/A And Other Stocks in Same Sector
MGNK Other Details
Segment | EQ | |
Market Capital | 955061.00 | |
Sector | ||
Industry | ||
Offical website | > echo $website ; ?> |
MGNK Address
MGNK Latest News
MGNK Business Profile
Mologen AG, a biotechnology company, develops immunotherapies for the treatment of oncology and human immunodeficiency virus (HIV). The company's lead product is Lefitolimod, an immunotherapeutic agent, which is in Phase III study for the treatment of metastatic colorectal cancer; Phase II trial for the treatment of small-cell lung cancer; and Phase Ib/IIa study of lefitolimod in HIV infected patients under antiretroviral therapy through collaborations with the Aarhus University Hospital in Denmark. Its lead product Lefitolimod is also under Phase I combination study with the checkpoint inhibitor Yervoy to treat advanced solid tumors in collaboration with MD Anderson Cancer Center at the University of Texas, the United States. In addition, the company is involved in the development of EnanDIM molecules, which are under pre-clinical development for cancer/anti-infective therapies; and MGN1601, a cell based therapeutic vaccine, which has completed Phase I/II trial for the treatment of renal cancer. Mologen AG was founded in 1998 and is headquartered in Berlin, Germany. Address: Fabeckstrasse 30, Berlin, Germany, 14195
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service